Clinical Trials in Boston

Showing 4801-4820 of 13,548 trials

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT05546580

Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat will be given in combination with gilteritinib, a drug that is already approved to treat patients with FLT3-mutated R/R AML.

Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory

Oryzon Genomics S.A.50 participantsStarted Nov 2022

Gilbert, Arizona, United States • Tucson, Arizona, United States • Miami, Florida, United States +10 more locations

COMPLETEDNA< 1 mile

Integrating Chiropractic Care and Mind-Body Training for the Treatment of Nonspecific Chronic Neck Pain

NCT06523036

Chronic neck pain is particularly prevalent among nurses. Nurses experiencing neck pain frequently report its impacts including decreased job satisfaction and reduced productivity. In recent years, non-pharmacologic approaches have increasingly been used treatments for the management of neck pain. Exercise and manual therapies represent two of the most common non-pharmacologic interventions for pain. The purpose of this study was to perform a pilot study of combined multimodal chiropractic care and Tai Chi for neck pain in nurses to help inform the design of a future, full-scale pragmatic trial.

Neck PainNurse-Patient Relations

Brigham and Women's Hospital21 participantsStarted May 2020

Boston, Massachusetts, United States

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Integrating Chiropractic Care and Mind-Body Training for the Treatment of Nonspecific Chronic Neck Pain

Find Trials by Condition in Boston

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Exploratory Study on Effect of Whitening Agent With Emulsion Gel in Xerostomic Population

A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Ergonomics in the Cardiac Catheterization Laboratory

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease